15.000
−1,96%
2026-10-15
Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -83.0% | -10.0% | 2 / 3 | -6.0% | -11.61 pp | -14.99 pp | +16.1% | 0.75 | 7.56 | 14,1 | −6,0% | 0,5 | −83,0% | 7.56 | 13.15 | −42,5% |
| Pts | 0 | 0 | 8 | 0 | 0 | 0 | 4 | 12 | 12 | |||||||
Valuation annotation:Price: 15.000 (close price on 2026-10-15)EPS (TTM): 1.983
Financial charts
1.Revenue & growth
VND bn14,1Q3/26
1.Revenue & growth
VND bn14,1Q3/26
2.Profit & growth
VND bn0,47Q3/26
3.Profit mix (Penman)
VND bn31,2Q3/26
4.Margins & cost structure
%59.6%Q3/26
5.Returns & cash cycle
% · days12.5%Q3/26
6.Earnings quality & cash
VND bn45,9Q3/26
7.Asset structure
VND bn357Q3/26
8.Funding & debt health
VND bn · times357Q3/26
9.Revenue backlog
VND bn0,00Q3/26
10.Valuation
times · %7,6×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %31Q3/26
Adjusted EPS growth, latest quarter
-83.0%
Average adjusted EPS growth, 3 quarters
-10.0%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26